Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose: SLE patients have elevated rates of acute myocardial infarctions (MI), but the sociodemographic groups that are most affected have not been well studied. We examined acute MI rates among SLE patients in different sociodemographic groups enrolled in Medicaid, the program providing medical insurance to low income individuals in the U.S., from 2000 to 2006.
Methods: From Medicaid Analytic eXtract (MAX) data, containing all billing claims from 2000-2006 for Medicaid patients from 47 U.S. states and Washington, D.C., we identified patients aged 18-65 with prevalent SLE (>3 SLE International Classification of Disease, 9threvision, [ICD-9 codes] of 710.0, >30 days apart). Demographic data included age, sex, race/ethnicity, U.S. region of residence (Northeast, Midwest, South or West) and calendar year. Within MAX inpatient claims files, ICD-9 code were used to identify all inpatient diagnoses for acute MI (ICD-9 codes 410.XX). CVD event incidence rates per 1,000 person-years with 95% CIs for patients with SLE in each sociodemographic group were calculated. We also performed Cox regression models stratified by sex and race/ethnicity, and adjusting for age, calendar year and U.S. region, to calculate hazards ratios for acute MIs in this population.
Results: We identified 43,351 patients with prevalent SLE. 40,417 (93%) were female. Racial and ethnic breakdown was: African American (35%), White (35%), Hispanic (14%), Asian (3%), and Native American (1%). The incidence rate for acute MI was 6.26 (95%CI 5.86, 6.69) per 1,000 person-years for the entire SLE population. Incidence rates were higher among males than females for all race/ethnicities (except for Native Americans for whom there were no events among males). (Table) Among women with SLE, Asians and Hispanics had the lowest incidence rates for acute MIs. Among males, incidence rates were also highest among White and African American patients, and lower in Asian and Hispanic SLE patients. Adjusted hazard ratios for acute MIs were significantly lower among Hispanic women compared to White women; however, they were not statistically lower among Asian women compared to White women. Although not statistically significant, lower hazard ratios for acute MIs were found in all non-White groups of men with SLE as well.
Conclusion: We found marked sex and race/ethnicity-specific variation in acute MI incidence rates and adjusted hazards ratios among Medicaid patients with SLE. The rates were higher among Whites and African American individuals. Further research is necessary to understand whether there is variation in acute MI prevention, cardiac risk factors, presentation, diagnosis and management among SLE patients in different sociodemographic groups.
Table. Incidence Rates and Adjusted Hazards Ratios for Hospitalizations for Acute Myocardial Infarctions among Medicaid patients with SLE in the U.S. by Race and Ethnicity, 2000-2006 |
|||||||
SLE Patients in Medicaid* |
Total Individuals |
N events |
IR** |
95% CI |
Person-years |
HR*** |
95% CI |
Females |
|||||||
White |
14,010 |
296 |
6.34 |
5.66 – 7.11 |
46,672 |
1.0 (ref.) |
– |
African American |
14,195 |
277 |
5.93 |
5.27 – 6.67 |
46,702 |
1.05 |
0.89 – 1.24 |
Asian |
1,095 |
**** |
2.81 |
1.51 – 5.22 |
3,558 |
0.68 |
0.36 – 1.28 |
Hispanic |
5,887 |
63 |
3.14 |
2.45 – 4.02 |
20,045 |
0.66 |
0.50 – 0.87 |
Native American |
519 |
11 |
6.65 |
3.68 – 12.01 |
1,654 |
1.21 |
0.66 – 2.22 |
Other/ Multiple |
2,667 |
72 |
7.71 |
6.12 – 9.71 |
9,344 |
1.23 |
0.95 – 1.60 |
Males |
|||||||
White |
1,007 |
44 |
15.89 |
11.82 – 21.35 |
2,769 |
1.0 (ref.) |
– |
African American |
877 |
22 |
8.68 |
5.72 – 13.18 |
2,535 |
0.63 |
0.38 – 1.07 |
Asian |
102 |
**** |
3.28 |
0.46 – 23.29 |
305 |
0.36 |
0.05 – 2.66 |
Hispanic |
373 |
**** |
3.78 |
1.42 – 10.07 |
1,057 |
0.40 |
0.14 – 1.15 |
Native American |
41 |
0 |
**** |
**** |
88 |
**** |
**** |
Other/ Multiple |
176 |
**** |
11.12 |
5 – 24.75 |
540 |
0.81 |
0.34 – 1.93 |
*Race/ethnicity missing for 2043 females and 359 males |
Disclosure:
M. Barbhaiya,
None;
C. H. Feldman,
None;
J. M. Franklin,
None;
J. Liu,
None;
J. M. Foody,
None;
M. A. Fischer,
None;
D. H. Solomon,
Lilly, Amgen, CORRONA,
2,
Lilly, BMS, Novartis, Pfizer,
6,
Lilly, BMS, Novartis,
9;
K. H. Costenbader,
None.
« Back to 2013 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/acute-myocardial-infarction-variation-among-u-s-medicaid-recipients-with-systemic-lupus-erythematosus-by-race-and-ethnicity-2000-2006/